Arvin Ighani

586 total citations
19 papers, 290 citations indexed

About

Arvin Ighani is a scholar working on Dermatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Arvin Ighani has authored 19 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Dermatology, 14 papers in Immunology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Arvin Ighani's work include Psoriasis: Treatment and Pathogenesis (13 papers), Dermatology and Skin Diseases (13 papers) and Autoimmune Bullous Skin Diseases (5 papers). Arvin Ighani is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (13 papers), Dermatology and Skin Diseases (13 papers) and Autoimmune Bullous Skin Diseases (5 papers). Arvin Ighani collaborates with scholars based in Canada, Thailand and Japan. Arvin Ighani's co-authors include Jensen Yeung, Jorge R. Georgakopoulos, Michelle Phung, Charles Lynde, Patrick Fleming, Neil H. Shear, Cathryn Sibbald, Scott R. Walsh, Wayne Gulliver and Morris F. Manolson and has published in prestigious journals such as Journal of the American Academy of Dermatology, JAMA Dermatology and Journal of Cutaneous Medicine and Surgery.

In The Last Decade

Arvin Ighani

19 papers receiving 282 citations

Peers

Arvin Ighani

IMMUN

DERMA

PFM

PHYSI

M. Viguier France

L. Manounah United Kingdom

Kamyar Farahi United States

Abby Jacobson United States

Maximilian Reinhardt Germany

Jai-Il Youn South Korea

Aleksandra G. Florek United States

Toshihiro Ito Japan

Mona Malakouti United States

Claudia de la Cruz United States

M. Viguier France

Arvin Ighani

185 ×0.8

IMMUN

144 ×1.0

DERMA

37 ×0.6

PFM

25 ×0.6

PHYSI

44 ×1.2

Citations per year, relative to Arvin Ighani Arvin Ighani (= 1×) peers M. Viguier

Countries citing papers authored by Arvin Ighani

Since Specialization

Citations

This map shows the geographic impact of Arvin Ighani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arvin Ighani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arvin Ighani more than expected).

Fields of papers citing papers by Arvin Ighani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arvin Ighani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arvin Ighani. The network helps show where Arvin Ighani may publish in the future.

Co-authorship network of co-authors of Arvin Ighani

This figure shows the co-authorship network connecting the top 25 collaborators of Arvin Ighani. A scholar is included among the top collaborators of Arvin Ighani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arvin Ighani. Arvin Ighani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Ighani, Arvin, Jorge R. Georgakopoulos, & Jensen Yeung. (2020). Tofacitinib for the treatment of psoriasis and psoriatic arthritis. Giornale Italiano di Dermatologia e Venereologia. 155(4). 400–410. 15 indexed citations

Ighani, Arvin, et al.. (2020). Biologic Treatment in Elderly Patients With Psoriasis: A Systematic Review. Journal of Cutaneous Medicine and Surgery. 24(2). 174–186. 29 indexed citations

Georgakopoulos, Jorge R., Arvin Ighani, Asfandyar Mufti, et al.. (2020). Short-Term Evaluation of the Real-World Efficacy and Safety of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis: A Canadian Multicenter Retrospective Cohort Study. Journal of Cutaneous Medicine and Surgery. 24(5). 468–473. 5 indexed citations

Ighani, Arvin, et al.. (2019). Off-label Uses of Topical Pimecrolimus. Journal of Cutaneous Medicine and Surgery. 23(4). 442–448. 4 indexed citations

Ighani, Arvin, et al.. (2019). Satisfaction and Awareness of Systemic Psoriasis Treatments: A National Survey Comparing Biologic and Nonbiologic Users. Journal of Cutaneous Medicine and Surgery. 23(2). 148–156. 11 indexed citations

Phung, Michelle, Arvin Ighani, Jorge R. Georgakopoulos, et al.. (2019). Off-Label High-Dose Secukinumab for the Treatment of Moderate-to-Severe Psoriasis. Journal of Cutaneous Medicine and Surgery. 23(4). 391–393. 12 indexed citations

Ighani, Arvin, Jorge R. Georgakopoulos, Neil H. Shear, Scott R. Walsh, & Jensen Yeung. (2018). Maintenance of therapeutic response after 1 year of apremilast combination therapy compared with monotherapy for the treatment of plaque psoriasis: A multicenter, retrospective study. Journal of the American Academy of Dermatology. 79(5). 953–956. 10 indexed citations

Georgakopoulos, Jorge R., Michelle Phung, Arvin Ighani, & Jensen Yeung. (2018). Efficacy and safety of switching to ixekizumab in secukinumab nonresponders with plaque psoriasis: A multicenter retrospective study of interleukin 17A antagonist therapies. Journal of the American Academy of Dermatology. 79(1). 155–157. 40 indexed citations

Phung, Michelle, et al.. (2018). Secukinumab dose optimization in adult psoriasis patients: A retrospective, multicenter case series. JAAD Case Reports. 4(4). 310–313. 15 indexed citations

10.

Ighani, Arvin, Neil H. Shear, Charles Lynde, et al.. (2018). Comparison of Management Guidelines for Moderate-to-Severe Plaque Psoriasis: A Review of Phototherapy, Systemic Therapies, and Biologic Agents. Journal of Cutaneous Medicine and Surgery. 23(2). 204–221. 34 indexed citations

11.

Ighani, Arvin, et al.. (2018). An Evaluation of Psoriasis Patient Perceptions and Understanding of Biosimilars: A Canadian Survey Comparing Biologic and Nonbiologic Users. Journal of Cutaneous Medicine and Surgery. 22(3). 365–367. 5 indexed citations

12.

Georgakopoulos, Jorge R., Michelle Phung, Arvin Ighani, & Jensen Yeung. (2018). Ixekizumab (Interleukin 17A Antagonist): 12-week Efficacy and Safety Outcomes in Real-world Clinical Practice. Journal of Cutaneous Medicine and Surgery. 23(2). 174–177. 18 indexed citations

13.

Ighani, Arvin, et al.. (2018). Medical, Surgical, and Wound Care Management of Ulcerated Infantile Hemangiomas: A Systematic Review. Journal of Cutaneous Medicine and Surgery. 22(5). 495–504. 9 indexed citations

14.

Georgakopoulos, Jorge R., et al.. (2018). Systemic Monotherapy Treatments for Generalized Pustular Psoriasis: A Systematic Review. Journal of Cutaneous Medicine and Surgery. 22(6). 591–601. 17 indexed citations

15.

Georgakopoulos, Jorge R., Arvin Ighani, & Jensen Yeung. (2018). Numerous asymptomatic dermal cysts: Diagnosis and treatment of steatocystoma multiplex.. PubMed. 64(12). 892–899. 7 indexed citations

16.

Ighani, Arvin, et al.. (2018). Efficacy and Safety of Apremilast Monotherapy for Moderate to Severe Psoriasis: Retrospective Study. Journal of Cutaneous Medicine and Surgery. 22(3). 290–296. 17 indexed citations

17.

Georgakopoulos, Jorge R., Arvin Ighani, Michelle Phung, & Jensen Yeung. (2017). Drug survival of secukinumab in real-world plaque psoriasis patients: A 52-week, multicenter, retrospective study. Journal of the American Academy of Dermatology. 78(5). 1019–1020. 26 indexed citations

18.

Ighani, Arvin. (2017). Herpes—A Not So Simple(x) History. JAMA Dermatology. 153(9). 910–910. 1 indexed citations

19.

Georgakopoulos, Jorge R., Arvin Ighani, & Jensen Yeung. (2017). Short- and Long-Term Management of an Acute Pustular Psoriasis Flare: A Case Report. Journal of Cutaneous Medicine and Surgery. 21(5). 452–456. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact